Marking and gene expression by a lentivirus vector in transplanted human and nonhuman primate CD34+ cells

Journal of Virology

Volumn 74, Issue 3, 2000, Pages 1286-1295

  An, Dong Sung ^b   Wersto, Robert P ^a   Agricola, Brian A ^a   Metzger, Mark E ^a   Lu, Stephanie ^b   Amado, Rafael G ^b   Chen, Irvin S Y ^b,c   Donahue, Robert E ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c 11 934 Factor Building ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; VIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LENTIVIRINAE; LONG TERMINAL REPEAT; MARKER GENE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; VIRUS REPLICATION;

ANIMALS; ANTIGENS, CD34; CYTOMEGALOVIRUS; GENE EXPRESSION; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HIV-1; HUMANS; LEUKEMIA VIRUS, MURINE; LEUKOPOIESIS; LIVER TRANSPLANTATION; LUMINESCENT PROTEINS; LYMPHOCYTE ACTIVATION; MACACA MULATTA; MICE; MICE, SCID; PROMOTER REGIONS (GENETICS); T-LYMPHOCYTES; THYMUS GLAND; TRANSDUCTION, GENETIC; VIRUS REPLICATION;

EID: 0001221797     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.3.1286-1295.2000     Document Type: Article

References (59)

1. Adachi, A., H. E. Gendelman, S. Koenig, T. Folks, R. Willey, A. Rabson, and M. A. Martin. 1986. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J. Virol. 59:284-291.
2. Akkina, R. K., J. D. Rosenblatt, A. G. Campbell, I. S. Chen, and J. A. Zack. 1994. Modeling human lymphoid precursor cell gene therapy in the SCID-hu mouse. Blood 84:1393-1398.
3. + cells with a human immunodeficiency virus type 1-based retroviral vector pseudotyped with vesicular stomatitis virus envelope glycoproiein G. J. Virol. 70:2581-2585.
4. Amado, R. G., and I. S. Y. Chen. 1999. The promise of gene therapy within reach? Science 285:674-676.
5. An, D. S., K. Morizono, Q. Li, H. Ma, S. Lu, and I. S. Y. Chen. 1999. An inducible human immunodeficiency virus type 1 (HIV-1) vector which effectively suppresses HIV-1 replication. J. Virol. 73:7671-7677.
6. An, D. S., Y. Koyanagi, J. Q. Zhao, R. Akkina, G. Bristol, N. Yamamoto, J. A. Zack, and I. S. Chen. 1997. High-efficiency transduction of human lymphoid progenitor cells and expression in differentiated T cells. J. Virol. 71:1397-1404.
7. Bodine, D. M., T. Moritz, R. E. Donahue, B. D. Luskey, S. W. Kessler, D. I. Martin, S. H. Orkin, A. W. Nienhuis, and D. A. Williams. 1993. Long-term in vivo expression of a murine adenosine deaminase gene in rhesus monkey hematopoietic cells of multiple lineages after retroviral mediated gene transfer into CD34+ bone marrow cells. Blood 82:1975-1980.
8. Bonyhadi, M. L., K. Moss, A. Voytorich, J. Auten, C. Kalfoglou, I. Plavec, S. Forestell, L. Su, E. Bohnlein, and H. Kaneshima. 1997. RevM10-expressing T cells derived in vivo from transduced human hematopoietic stem-progenitor cells inhibit human immunodeficiency virus replication. J. Virol. 71: 4707-4716.
9. Buchschacher, G. L. J., and A. T. Panganiban. 1992. Human immunodeficiency virus vectors for inducible expression of foreign genes. J. Virol. 66: 2731-2739.
10. Bukovsky, A. A., J. P. Song, and L. Naldini. 1999. Interaction of human immunodeficiency virus-derived vectors with wild-type virus in transduced cells. J. Virol. 73:7087-7092.
11. Bukrinsky, M. I., S. Haggerty, M. P. Dempsey, N. Sharova, A. Adzhubel, L. Spitz, P. Lewis, D. Goldfarb, M. Emennan, and M. Stevenson. 1993. A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells. Nature 365:666-669.
12. Bunnell, B. A., M. Metzger, E. Byrne, R. A. Morgan, and R. E. Donahue. 1997. Efficient in vivo marking of primary CD4+ T lymphocytes in nonhuman primates using a gibbon ape leukemia virus-derived retroviral vector. Blood 89:1987-1995.
13. Bunting, K. D., M. Y. Sangster, J. N. Ihle, and B. P. Sorrentino. 1998. Restoration of lymphocyte function in Janus kinase 3-deficient mice by retroviral-mediated gene transfer. Nat. Med. 4:58-64.
14. Burns, J. C., T. Friedmann, W. Driever, M. Burrascano, and J. K. Yee. 1993. Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and non-mammalian cells. Proc. Natl. Acad. Sci. USA 90:8033-8037.
15. Corebeau, P., and F. Wong-Staal. 1998. Anti HIV effects of HIV vectors. Virology 243:268-274.
16. Dick, J. E., M. Bhatia, O. Gan, U. Kapp, and J. C. Wang. 1997. Assay of human stem cells by repopulation of NOD/SCID mice. Stem Cells 15(Suppl. 1):199-203.
17. Donahue, R. E., B. A. Bunnell, M. C. Zink, M. E. Metzger, R. P. Westro, M. R. Kirby, T. Unangst, J. E. Clements, and R. A. Morgan. 1998. Reduction in SIV replication in rhesus macaques infused with autologous lymphocytes engineered with antiviral genes. Nat. Med. 4:181-186.
18. Donahue, R. E., S. W. Kessler, D. Bodine, K. McDonagh, C. Dunbar, S. Goodman, B. Agricola, E. Byrne, M. Raffeld, and R. Moen. 1992. Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer. J. Exp. Med. 176:1125-1135.
19. Donahue, R. E., M. R. Kirby, M. E. Metzger, B. A. Agricola, S. E. Sellers, and H. M. Cullis. 1996. Peripheral blood CD34+ cells differ from bone marrow CD34+ cells in Thy-1 expression and cell cycle status in nonhuman primates mobilized or not mobilized with granulocyte colony-stimulating factor and/or stem cell factor. Blood 87:1644-1653.
20. Dunbar, C. E., M. Cottler-Fox, J. A. O'Shaughnessy, S. Doren, C. Carter, R. Berenson, S. Brown, R. C. Moen, J. Greenblatt, and F. M. Stewart. 1995. Retrovirally marked CD34-enriched peripheral blood and hone marrow cells contribute to long-term engraftment after autologous transplantation. Blood 85:3048-3057.
21. Gallay, P., T. Hope, D. Chin, and D. Trono. 1997. HIV-1 infection of nondividing cells through the recognition of integrase by the importin/karyopherin pathway. Proc. Natl. Acad. Sci. USA 94:9825-9830.
22. Gallichan, W. S., T. Kafri, T. Krahl, I. M. Verma, and N. Sarvetnick. 1998. Lentivirus-mediated transduction of islet grafts with interleukin 4 results in sustained gene expression and protection from insulitis. Hum. Gene Ther. 9:2717-2726.
23. Geretti, A. M. 1999. Simian immunodeficiency virus as a model of human HIV disease. Rev. Med. Virol. 9:57-67.
24. Goldman, M. J., P. S. Lee, J. S. Yang, and J. M. Wilson. 1997. Lentiviral vectors for gene therapy of cystic fibrosis. Hum. Gene Ther. 8:2261-2268.
25. Greiner, D. L., R. A. Hesselton, and L. D. Shultz. 1998. SCID mouse models of human stem cell engraftment. Stem Cells 16:166-177.
26. Heinzinger, N. K., M. I. Bukinsky, S. A. Haggerty, A. M. Ragland, V. Kewalramani, M. A. Lee, H. E. Gendelman, L. Ratner, M. Stevenson, and M. Emerman. 1994. The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells. Proc. Natl. Acad. Sci. USA 91:7311-7315.
27. Kafri, T., U. Blomer, D. A. Peterson, F. H. Gage, and I. M. Verma. 1997. Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors. Nat. Genet. 17:314-317.
28. Kaptein, L. C., V. W. Van Beusechem, I. Riviere, R. C. Mulligan, and D. Valerio. 1997. Long-term in vivo expression of the MFG-ADA retroviral vector in rhesus monkeys transplanted with transduced bone marrow cells. Hum. Gene Ther. 8:1605-1610.
29. Kay, M. A. 1998. Hepatic gene therapy for haemophilia B. Haemophilia 4:389-392.
30. Kim, V. N., K. Mitrophanous, S. M. Kingsman, and A. J. Kingsman. 1998. Minimal requirement for a lentivirus vector based on human immunodeficiency virus type 1. J. Virol. 72:811-816.
31. Kimpton, J., and M. Emerman. 1992. Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated β-galactosidase gene. J. Virol. 66: 2232-2239.
32. 1b, phase of the cell cycle is required for completion of human immunodeficiency virus type 1 reverse transcription in T cells. J. Virol, 72:3161-3168.
33. Landau, N. R., and D. R. Littman. 1992. Packaging system for rapid production of murine leukemia virus vectors with variable tropism. J. Virol. 66:5110-5113.
34. Lewis, P. F., and M. Emerman. 1994. Passage through mitosis is required for oncoretroviruses hut not for the human immunodeficiency virus. J. Virol. 68:510-516.
35. Lorre, K., A. Kasran, F. Van Vaeck, M. de Boer, and J. L. Ceuppens. 1994. Interleukin-1 and B7/CD28 interaction regulate interleukin-6 production by human T cells. Clin, Immunol. Immunopathol. 70:81-90.
36. Marcello, A., and I. Giaretta. 1998. Inducible expression of herpes simplex virus thymidine kinase from a bicistronic HIV1 vector. Res. Virol. 149:419-431.
37. McCune, J. M., R. Namikawa, H. Kaneshima, L. D. Shultz, M. Lieberman, and I. L. Weissman. 1988. The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function. Science 241:1632-1639.
38. Miller, D. G., M. A. Adam, and A. D. Miller. 1990. Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol. Cell. Biol. 10:4239-4242. (Erratum, 12:433, 1992.)
39. Miyoshi, H., M. Takahashi, F. H. Gage, and I. M. Verma. 1997. Stable and efficient gene transfer into the retina using an HIV-based lentiviral vector. Proc. Natl. Acad. Sci. USA 94:10319-10323.
40. Miyoshi, H., U. Blomer, M. Takahashi, F. H. Gage, and I. M. Verma. 1998. Development of a self-inactivating lentivirus vector. J. Virol. 72:8150-8157.
41. Miyoshi, H., K. A. Smith, D. E. Mosier, I. M. Verma, and B. E. Torbett. 1999. Transduction of human CD34+ cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors. Science 283:682-686.
42. Mochizuki, H., J. P. Schwartz, K. Tanaka, R. O. Brady, and J. Reiser. 1998. High-titer human immunodeficiency virus type 1-based vector systems for gene delivery into nondividing cells. J. Virol. 72:8873-8883.
43. Naldini, L., U. Blomer, P. Gallay, D. Ory, R. Mulligan, F. H. Gage, I. M. Verma, and D. Trono. 1996. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272:263-267.
44. Naldini, L., U. Blomer, F. H. Gage, D. Trono, and I. M. Verma. 1996. Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc. Natl. Acad. Sci. USA 93:11382-11383.
45. National Institutes of Health. 1985. Guide for the care and use of laboratory animals, rev. ed. Department of Health and Human Services publication no. (NIH) 85-23. National Institutes of Health, Bethesda, Md.
46. Parolin, C., T. Dorfman, G. Palu, H. Gottlinger, and J. Sodroski. 1994. Analysis in human immunodeficiency virus type 1 vectors of cis-acting sequences that affect gene transfer into human lymphocytes. J. Virol. 68:3888-3895.
47. Persons, D. A., J. A. Allay, J. M. Riberdy, R. P. Wersto, R. E. Donahue, B. P. Sorrentino, and A. W. Nienhuis. 1998. Use of the green fluorescent protein as a marker to identify and track genetically modified hematopoietic cells. Nat. Med. 4:1201-1205.
48. Poznansky, M., A. Lever, L. Bergeron, W. Haseltine, and J. Sodroski. 1991. Gene transfer into human lymphocytes by a defective human immunodeficiency virus type 1 vector. J. Virol. 65:532-536.
49. Reiser, J., G. Harmison, S. Kluepfel-Stahl, R. O. Brady, S. Karlsson, and M. Schubert. 1996. Transduction of nondividing cells using pseudotyped defective high-liter HIV type 1 particles. Proc. Natl. Acad. Sci. USA 93:15266-15271.
50. Roe, T., T. C. Reynolds, G. Yu, and P. O. Brown. 1993. Integration of murine leukemia virus DNA depends on mitosis. EMBO J. 12:2099-2108.
51. Shultz, L. D., P. A. Schweitzer, S. W. Christianson, B. Gott, I. B. Schweitzer, B. Tennent, S. McKenna, L. Mobraaten, T. V. Rajan, and D. L. Greiner. 1995. Multiple defects in innate and adaptive immunologic function in NOD/ LtSz-scid mice. J. Immunol. 154:180-191.
52. Sutton, R. E., H. T. Wu, R. Rigg, E. Bohnlein, and P. O. Brown. 1998. Human immunodeficiency virus type 1 vectors efficiently transduce human hematopoietic stem cells. J. Virol. 72:5781-5788.
53. Takahashi, M., H. Mijoshi, I. M. Verma, and F. H. Gage. 1999. Rescue of photoreceptor degeneration in the rd mouse by human immunodeficiency virus vector-mediated gene transfer. J. Virol. 73:7812-7816.
54. Tisdale, J. F., Y. Hanazono, S. E. Sellers, B. A. Agricola, M. E. Metzger, R. E. Donahue, and C. E. Dunbar. 1998. Ex vivo expansion of genetically marked rhesus peripheral blood progenitor cells results in diminished long-term repopulating ability. Blood 92:1131-1141.
55. Uchida, N., R. E. Sutton, A. M. Friera, D. He, M. J. Reitsma, W. C. Chang, G. Veres, R. Scollay, and I. L. Weissman. 1998. HIV, but not murine leukemia virus, vectors mediate high efficiency gene transfer into freshly isolated G0/G1 human hematopoietic stem cells. Proc. Natl. Acad. Sci. USA 95:11939-11944.
56. Verwilghen, J., M. L. Baroja, F. Van Vaeck, J. Van Damme, and J. L. Ceuppens. 1991. Differences in the stimulating capacity of immobilized anti-CD3 monoclonal antibodies: variable dependence on interleukin-1 as a helper signal for T-cell activation. Immunology 72:269-276.
57. von Schwedler, U., R. S. Kornbluth, and D. Trono. 1994. The nuclear localization signal of the matrix protein of human immunodeficiency virus type 1 allows the establishment of infection in macrophages and quiescent T lymphocytes. Proc. Natl. Acad. Sci. USA 91:6992-6996.
58. Xu, L. C., S. Karlsson, E. R. Byrne, S. Kluepfel-Stahl, S. W. Kessler, B. A. Agricola, S. Sellers, M. Kirby, C. E. Dunbar, and R. O. Brady. 1995. Long-term in vivo expression of the human glucocercbrosidase gene in nonhuman primates after CD34+ hematopoietic cell transduction with cell-free retroviral vector preparations. Proc. Natl. Acad. Sci. USA 92:4372-4376.
59. Zack, J. A., S. J. Arrigo, S. R. Weitsman, A. S. Go, A. Haislip, and I. S. Chen. 1990. HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 61:213-222.